# The Organ Protection of Astragalus in Subjects With Metabolic Syndrome

> **NCT01847807** · PHASE3 · COMPLETED · sponsor: **LanZhou University** · enrollment: 210 (actual)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DRUG:** low dose Astragalus
- **DRUG:** high dose astagalus

## Key facts

- **NCT ID:** NCT01847807
- **Lead sponsor:** LanZhou University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2015-06
- **Final completion:** —
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2015-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01847807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01847807, "The Organ Protection of Astragalus in Subjects With Metabolic Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01847807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*